Although he only rates BDX "in-line", it would be hard to read more uniformly favorable comments about BDX and its outlook than are included in Lawrence Keusch's report on BDX this morning. He sees fair value at 42.
oh my gosh...you mean you don't see the connection between DSL and medical testing applications?what ever
Any other analysts' reports out yet? It's apparent the Street is not very impressed with either the results or the prospects.
the street is full of liars and manipulators so don't trust them anywaydamn crooks are everywhere